University of California San Francisco
Give to UCSFTreating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers who have outlined their vision of cell-based therapeutics as a “third pillar of medicine."
The Li Ka Shing Foundation has pledged $2 million to support UCSF’s efforts to advance precision medicine, an emerging field aimed at revolutionizing medical research and patient care.
<p>A UCSF team has developed an ambitious online cardiovascular study using smartphones, with the goal of enrolling 1 million people from all over the world to improve heart health.</p>
<p>Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. UCSF School of Pharmacy's Kathryn Phillips, PhD, will lead the first national study to analyze how physicians and patients evaluate the benefits and risks posed by this profusion of information.</p>
The immune system’s T cells, while coordinating responses to diseases and vaccines, act like honey bees sharing information about the best honey sources, according to a new study by scientists at UCSF.
Scientists at UCSF have found a more precise way to turn off genes, a finding that will speed research discoveries and biotech advances and may eventually prove useful in reprogramming cells to regenerate organs and tissues.